Currently, there are 227.32M common shares owned by the public and among those 205.82M shares have been available to trade.
The company’s stock has a 5-day price change of -26.45% and -7.15% over the past three months. RUN shares are trading -50.98% year to date (YTD), with the 12-month market performance down to -32.65% lower. It has a 12-month low price of $5.38 and touched a high of $22.26 over the same period. RUN has an average intraday trading volume of 20.30 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -19.31%, -22.97%, and -40.92% respectively.
Institutional ownership of Sunrun Inc (NASDAQ: RUN) shares accounts for 108.50% of the company’s 227.32M shares outstanding.
It has a market capitalization of $1.42B and a beta (3y monthly) value of 2.61. The earnings-per-share (ttm) stands at -$12.14. Price movements for the stock have been influenced by the stock’s volatility, which stands at 26.50% over the week and 16.87% over the month.
Analysts forecast that Sunrun Inc (RUN) will achieve an EPS of -0.23 for the current quarter, -0.12 for the next quarter and -1.02 for current fiscal year. The lowest estimate earnings-per-share for the quarter is -0.75 while analysts give the company a high EPS estimate of -0.75. Comparatively, EPS for the current quarter was 0.55 a year ago. Earnings per share for the fiscal year are expected to increase by 97.84%, and -67.46% over the next financial year.
Looking at the support for the RUN, a number of firms have released research notes about the stock. RBC Capital Mkts stated their Sector Perform rating for the stock in a research note on June 18, 2025, with the firm’s price target at $5. KeyBanc Capital Markets coverage for the Sunrun Inc (RUN) stock in a research note released on June 17, 2025 offered a Underweight rating with a price target of $6. Jefferies was of a view on June 11, 2025 that the stock is Underperform, while BNP Paribas Exane gave the stock Neutral rating on May 22, 2025, issuing a price target of $10. BMO Capital Markets on their part issued Underperform rating on May 22, 2025.
